Insulin Lispro
Product Overview
| Generic Name | Insulin Lispro |
| Brand Name(s) | Humalog |
| Category | Insulin |
| Form | Vial 10mL |
| Strength | 100iu/mL |
| Therapeutic Class | Antidiabetic; Rapid‑acting insulin analogue |
| ATC Code | A10AB04 |
Manufacturing & Regulatory
| Manufacturer | Eli Lilly and Company India Pvt Ltd |
| GMP Compliance | WHO-GMP |
| DMF/CEP | Not publicly disclosed |
| COFEPRIS | Under Registration (2025) |
| Free Sale Certificate | Yes |
Logistics & Export
| MOQ | 5,000 units |
| Shelf Life | 24 - 36 months |
| Storage | Store at 2–8 °C (36–46 °F); do not freeze |
| Incoterms | Ex-Works Mexico |
| Lead Time | 7 - 10 Business Days |
Documentation Available Upon Request
| Certificate of Analysis (PDF) | Yes |
| SDS-Safety Data Sheet (PDF) | Upon Request |
| CTD Summary (PDF) | Upon Request |
Special Notes
Indication/Usage: Rapid preprandial insulin to control post‑meal hyperglycemia in type 1 and type 2 diabetes; available in prandial and premixed formats.
- Recombinant human insulin analogue (biosynthetic)